Cure Genetics Co., Ltd. was founded in July 2016. The company brings together scientists from * research institutions (Yale, MIT, Georgia Tech/Emory University, National University of Singapore) as well as expert advisors including academicians of the Chinese Academy of Sciences and national "*" talents. It is a precision medicine company with both * precision gene editing-delivery technology and clinical application translation capabilities, mainly dedicated to the research and development of novel therapeutic technologies and drugs for refractory tumors, complex human genetic diseases and other difficult diseases.
The company will fully leverage the cross-combination of multiple technological advantages, combined with gene sequencing and systems biology analysis methods, to achieve safe, efficient and targeted editing of single or multiple gene loci at the cellular, animal and human levels, break through the bottleneck of preclinical research, reduce clinical research risks, and deploy medical technology and new drug development to meet medical market demands; at the same time, the company will provide multi-level outsourcing services to research institutions and enterprises, comprehensively improving the level of life sciences, thereby accelerating the process of cooperation and independent industrialization, and striving to become a clinical application translation company of China's original gene editing technology.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows